| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $79K | +0.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $78K | +0.0% |
| R&D Expense | $2.3M | +43.7% |
| SG&A Expense | $3.5M | +38.8% |
| Operating Income | -$5.7M | -43.4% |
| Interest Expense | $84K | -7.7% |
| Net Income | -$5.6M | -37.4% |
| EPS (Basic) | -$15.03 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | +23.5% |
| Short-term Investments | $4.0M | +0.0% |
| Accounts Receivable | $3K | -87.2% |
| Inventory | $166K | +0.0% |
| Current Assets | $2.7M | -58.9% |
| Total Assets | $4.4M | -47.3% |
| Current Liabilities | $2.5M | +106.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | -36.6% |
| Capital Expenditures | $62K | +54.9% |
| Investing Cash Flow | $4.1M | +122.0% |
| Financing Cash Flow | $1.5M | — |
| Free Cash Flow | -$5.1M | -36.8% |
| -4320.6% |
| EPS (Diluted) | -$15.03 | -4320.6% |
| Total Liabilities |
| $3.8M |
| -5.4% |
| Stockholders' Equity | $608K | -86.1% |